Kei Kawana - Concepedia

Author

Kei Kawana

Also Known As

K Kawana, K. Kawana, KEI KAWANA, Kawana Kei, Kawana, K., Kawana, Kei, Kei KAWANA, Kei Kawana, Lininger, Ruth, Takuma Fujii

425

Publications

6.3K

Citations

H-Index

172

Concepts

All Affiliations

The University of Tokyo Nihon University National Center for Global Health and Medicine National Institute of Infectious Diseases Keio University

About

Kei Kawana is an author at The University of Tokyo specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	73	3.3K
2	Public Health	13	14	476
3	Health Sciences	6	6	222
4	Natural Sciences	4	4	71
5	Engineering	2	2	117

Kei Kawana

150

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602 Takashi Onda, Toyomi Satoh, Toshiaki Saito, European Journal of Cancer Gynecologic SurgerySurgical OncologyTreatment InvasivenessNeoadjuvant ChemotherapyGynecological Surgery	2016	246
Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial Takashi Onda, Toyomi Satoh, Gakuto Ogawa, European Journal of Cancer Gynecologic SurgerySurgical OncologyGynecological SurgeryNeoadjuvant ChemotherapyMedicine	2020	207
The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas Keiko Shoji, Katsutoshi Oda, Shunsuke Nakagawa, British Journal of Cancer	2009	151
Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy Atsutaka Minagawa, Toshiaki Yoshikawa, Masaki Yasukawa, Cell stem cell Tumor ImmunologyCancer ImmunosurveillanceT-regulatory CellImmunologyImmune Checkpoint Inhibitor	2018	140
Common Neutralization Epitope in Minor Capsid Protein L2 of Human Papillomavirus Types 16 and 6 Kei Kawana, Hiroyuki Yoshikawa, Yuji Taketani, Journal of Virology	1999	131
CD1d, a Sentinel Molecule Bridging Innate and Adaptive Immunity, Is Downregulated by the Human Papillomavirus (HPV) E5 Protein: a Possible Mechanism for Immune Evasion by HPV Shiho Miura, Kei Kawana, Danny J. Schust, Journal of Virology	2010	126
Oral vaccination against HPV E7 for treatment of cervical intraepithelial neoplasia grade 3 (CIN3) elicits E7-specific mucosal immunity in the cervix of CIN3 patients Kei Kawana, Katsuyuki Adachi, Satoko Kojima, Vaccine VaccinationE7-specific Mucosal ImmunityMucosal VaccinationOral VaccinationCancer-associated Virus	2014	106
Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma Koji Matsuo, Yutaka Takazawa, Malcolm S. Ross, Annals of Oncology Tumoral PathologySarcoma ComponentsMedicineSurgical PathologyGynecology	2016	102
Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7 Katsuyuki Adachi, Kei Kawana, Terufumi Yokoyama, Vaccine VaccinationMucosal VaccinationVaccine DevelopmentLactobacillus Casei VaccineHuman Papillomavirus Vaccines	2010	98
Human Papillomavirus Type 16 Minor Capsid Protein L2 N-Terminal Region Containing a Common Neutralization Epitope Binds to the Cell Surface and Enters the Cytoplasm Yukiko Kawana, Kei Kawana, Hiroyuki Yoshikawa, Journal of Virology	2001	85

Page 1